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Background. The flavonoid luteolin has anti-inflammatory properties both in vivo and in vitro. However, the impact of luteolin
on experimental models of colitis is unknown. Methodology/Principal Findings. To address the therapeutic impact of
luteolin, NF-kB
EGFP transgenic mice were fed a chow diet containing 2% luteolin- or isoflavone-free control chow (AIN-76), and
acute colitis was induced using 3% dextran sodium sulfate (DSS). Additionally, development of spontaneous colitis was
evaluated in IL-10
2/2;NF-kB
EGFP transgenic mice fed 2% luteolin chow diet or control chow diet. Interestingly, NF-kB
EGFP
transgenic mice exposed to luteolin showed worse DSS-induced colitis (weight loss, histological scores) compared to control-
fed mice, whereas spontaneous colitis in IL-10
2/2;NF-kB
EGFP mice was significantly attenuated. Macroscopic imaging of live
resected colon showed enhanced EGFP expression (NF-kB activity) in luteolin-fed mice as compared to control-fed animals
after DSS exposure, while cecal EGFP expression was attenuated in luteolin-fed IL-10
2/2 mice. Interestingly, confocal
microscopy showed that EGFP positive cells were mostly located in the lamina propria and not in the epithelium. Caspase 3
activation was significantly enhanced whereas COX-2 gene expression was reduced in luteolin-fed, DSS-exposed NF-kB
EGFP
transgenic mice as assessed by Western blot and immunohistochemical analysis. In vitro, luteolin sensitized colonic epithelial
HT29 cells to TNFa-induced apoptosis, caspase 3 activation, DNA fragmentation and reduced TNFa-induced C-IAP1, C-IAP2 and
COX-2 gene expression. Conclusions/Significance. We conclude that while luteolin shows beneficial effects on spontaneous
colitis, it aggravates DSS-induced experimental colitis by blocking NF-kB-dependent protective molecules in enterocytes.
Citation: Karrasch T, Kim J-S, Jang BI, Jobin C (2007) The Flavonoid Luteolin Worsens Chemical-Induced Colitis in NF-kB
EGFP Transgenic Mice through
Blockade of NF-kB-Dependent Protective Molecules. PLoS ONE 2(7): e596. doi:10.1371/journal.pone.0000596
INTRODUCTION
The gastrointestinal tract of higher organisms is lined by a single
layer of intestinal epithelial cells. This physical barrier separates
subepithelial mucosal immune cells such as lymphocytes and
myeloid cells from a variety of antigenic substances present within
the intestinal lumen (e.g. bacteria, bacterial products, food
antigens) [1,2]. Consequently, the integrity of the epithelial barrier
is essential for the maintenance of host homeostasis, as it prevents
a dysregulated uptake of luminal antigens. The incidence and
prevalence of ulcerative colitis and Crohn’s disease, collectively
referred to as inflammatory bowel diseases (IBD), have been
increasing in developed countries worldwide over the last few
decades [3]. Of note, the knowledge of basic molecular and
cellular mechanisms leading to IBD has significantly increased
over the past decade [4]. For example, multiple studies support the
concept that an improper activation of effector T cells in
conjunction with insufficient regulatory T cell activity are key
events leading to the development of IBD [5]. Interestingly, the
endogenous intestinal flora itself seems to play an important role in
initiating the dysregulated host immune response [6], leading to
the release of a number of inflammatory mediators such as IL-1,
IL-6, IL-12, IL-23, TNFa and IFNc that participate in the
pathology of the disease [7]. The transcription factor NF-kB
controls the production of many of these inflammatory mediators,
and we recently demonstrated its important role in driving
bacteria-induced chronic intestinal inflammation [8]. Consequent-
ly, this transcriptional system represents a potential therapeutic
target to treat IBD [9,10].
Mainstream treatments to manage IBD are largely based on
immunosuppressive approaches with broad acting agents such as
prednisone, cyclosporin A and tacrolimus (FK506) [11]. Although
these are relatively effective, a number of patients develop
significant side effects and/or become unresponsive to them.
These concerns and the perception that alternative medicine is
‘‘healthier’’ than classical therapeutic options lead a growing
segment of the population to seek alternative treatments to
ameliorate various disorders including chronic intestinal inflam-
mation [12]. This is clearly exemplified by the considerable
amount of money spent by the general population on alternative
medicine with an estimated world market of 62 billion dollars
[13,14]. Herbal medicine encompassing extracts or active
components derived from plants, barks, roots, leaves, flowers,
and fruits represents an extremely popular segment of alternative
medicine. However, despite their clear popularity, absence of
empirical data showing efficacy and mechanisms of action in vivo
prevents their incorporation into mainstream medicine.
Of interest, a large number of dietary products have been
shown to inhibit NF-kB activity in different cell systems [15].
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in vegetables including celery, sage, carrots and broccoli, and
a healthy diet is believed to contain between 2 mg and 125 mg of
luteolin per day [16,17]. We recently demonstrated that luteolin
suppresses LPS-induced NF-kB signaling both in vivo and in vitro
through inhibition of the IkB-kinase complex [18]. In addition,
numerous other studies have shown the anti-inflammatory action
of this flavonoid both in vivo and in vitro [19–24]. Consequently,
this polyphenolic compound may have a beneficial impact either
in treating IBD or preventing their development.
In the present study, we examined the impact of luteolin on the
DSS model of acute colitis in mice. To follow patterns of NF-kB
activation, we conducted experiments using NF-kB
EGFP and IL-
10
2/2;NF-kB
EGFP transgenic mice, which express the reporter
gene enhanced green fluorescent protein (EGFP) under control of
the NF-kB promoter. We found that luteolin significantly
enhanced intestinal epithelial cell caspase-3 activation and
prevented the induction of cytoprotective molecules such as
COX-2 following DSS-exposure. DSS-exposed, luteolin-fed mice
demonstrated more severe colitis than control-fed animals,
whereas spontaneous colitis in IL-10
2/2;NF-kB
EGFP mice was
significantly attenuated. We conclude that while luteolin shows
beneficial effects on spontaneous colitis, it aggravates DSS-induced
experimental colitis by blocking NF-kB-dependent protective
molecules in enterocytes.
MATERIALS AND METHODS
DSS-induced acute colitis
The NF-kB
EGFP transgenic mice were described previously [25].
These mice allow the real-time assessment of NF-kB activity
(EGFP expression) during various experimental treatments. Mice
were maintained in standard housing cages in a specific pathogen
free (SPF) environment and allowed to drink and feed ad libitum
at all times. Luteolin (SYNORx; San Clemente, CA) was
incorporated in standard laboratory chow AIN-76 in different
amounts (weight-percentages: 0.5%, 2%, 5%) (Research Diets Inc;
New Brunswick, NJ). Mice (7/group) were pre-fed luteolin-chow
(0.5%, 2%, 5%) or control chow (AIN-76) for 3 days (loading
period) as described previously [26,27]. After this time, mice were
given 3% DSS (MP Biomedicals; Aurora, OH) in drinking water
for an additional 6 days. Control mice were given water. Water
consumption was comparable between the different groups.
Similarly, chow consumption (control AIN76 and luteolin) was
comparable between DSS and water control groups, both before
and during the induction of colitis (daily consumption approxi-
mately 1.6 g/mouse, equaling 32 mg luteolin; differen-
ces#0.08 g/day or 5%). Mice were monitored daily for weight
loss as well as signs of rectal bleeding (Hemoccult, Beckmann
Coulter Inc; Fullerton, CA). At day 6 of DSS administration, mice
were sacrificed, sections were taken from the distal colon for
histological assessment of inflammation and EGFP-expression was
imaged as described below.
Spontaneous colitis in IL-10
2/2;NF-kB
EGFP transgenic
mice
IL-10
wt/wt and IL-10
2/2 mice (Sv129 background) were cross-
bred to NF-kB
EGFP mice (C57Bl/6 background), and IL-10
wt/
wt;NF-kB
EGFP and IL-10
2/2;NF-kB
EGFP mice generated in the
F2-generation were derived into germ-free condition. Germ-free
IL-10
wt/wt;NF-kB
EGFP and IL-10
2/2;NF-kB
EGFP littermates were
transferred to a specific-pathogen-free (SPF) environment and
immediately placed on a diet containing 2%-luteolin versus AIN-
76-control-chow (7/group). After 4 weeks, mice were sacrificed,
sections were taken from cecum and distal colon for histological
assessment of inflammation and EGFP-expression was imaged as
described below. All animal experiments were approved by the
Institutional Animal Care and Use Committee of the University of
North Carolina at Chapel Hill.
Sample collection and histological evaluation
Mice were sacrificed at designated time-points by CO2 asphyx-
iation. The entire colon was dissected and flushed with ice-cold
PBS. Colonic cross-sections were taken, fixed in 10% formalin for
24 h and embedded in paraffin to provide sections for histological
evaluation. Severity of colitis was evaluated in Hematoxylin-Eosin-
stained sections by an experienced investigator blinded to the
experimental conditions. For DSS-induced colitis, the distal colon
was evaluated because it has been demonstrated to be the most
severely affected colonic segment in DSS-induced colitis [28,29]
and to provide a score representing the disease severity in the
entire colon [30]. Coded sections were scored using a validated
scoring system developed by Cooper [29] and Dieleman [31], and
modified by Williams [30] using a scale of 0 to 40. For each
animal, 2 sections approximately 400 mm apart were scored and
averaged. For spontaneous colitis in IL-10
2/2 mice, mucosal
inflammation was evaluated in cross-sections of the cecum and the
distal colon separately. Sections were scored in a blinded fashion
on a scale from 0 to 4, based on the degree of lamina propria
mononuclear cell infiltration, crypt hyperplasia, goblet cell
depletion and architectural distortion, as previously described
[32].
Immunohistochemical evaluation
Colonic sections were prepared as described above. Immunohis-
tochemical staining for activated caspase 3 (antibodies to cleaved
caspase-3 (Asp175); Cell Signaling Technology Inc; Beverly, MA)
and cyclooxygenase 2 (COX-2) (Cayman Chemical; Ann Arbor,
MI) was performed according to the manufacturer’s directions.
The sections were counterstained with a mixture of methyl-green
and alcian-blue. Two different sections (per animal) approximately
400 mm apart were evaluated, and representative sections are
shown.
Primary intestinal epithelial cell isolation
Primary intestinal epithelial cells were isolated as described
previously [33]. Briefly, colons were opened longitudinally, and
colonic intestinal epithelial cells were separated by shaking the
colons in a solution containing 3 mM EDTA and 0.5 mM DTT
for 90 min. The remaining tissue was discarded and epithelial cells
in the supernatant were spun down at 1000 rpm for 5 min. The
cell pellet was then directly lysed in 16Laemmli buffer. Vimentin
or CD64, markers for myofibroblasts and myeloid cells re-
spectively, were not detected, whereas the epithelial marker
cytokeratin was strongly expressed in our epithelial cell prepara-
tion as assayed by Western blot analysis (data not shown).
HT29 cell culture, stimulation, cell and whole colonic
tissue protein isolation
Human transformed colonic epithelial HT29 cells (passage 20–30)
(American Type Culture Collection (ATCC); Manassas, VA) were
cultured as described previously [34]. Before experiments, cells
were starved overnight in serum-reduced media (1% serum).
Where indicated, HT29 cells were treated with luteolin
(SYNORx; San Clemente, CA) dissolved in DMSO, TNFa
(R&D Systems; Minneapolis, MN) or solvent control for
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effect on the various in vitro readouts (data not shown). Stimulated
or control treated HT29 cells were collected and directly lysed in
1X Laemmli buffer.
The colons from mice in the various groups were dissected,
flushed with ice-cold PBS and homogenized for 15 s with
a polytron (IKA Works Inc; Wilmington, NC) in a solution
containing 50 mM Hepes, 150 mM NaCl, 20 mM NaPyropho-
sphate, 100 mM NaF, 1% Triton X-100, 10 mM EDTA and 1X
Proteinase inhibitors (Complete Mini, Roche Diagnostics GmbH;
Penzberg, Germany). After incubation at 4uC for 30 min with
gentle agitation, undissolved contents were spun down and the
supernatant mixed 1:1 with 26Laemmli buffer.
Western Blot analysis
The protein concentration of lysates was measured using Bio-
Rad quantification assay (Bio-Rad Laboratories; Hercules, CA).
Proteins (20 mg) were separated using 10% (13% for caspase
analysis) SDS-PAGE and transferred to nitrocellulose mem-
branes. Antibodies to COX-2 (Cayman Chemicals; Ann Arbor,
MI), cleaved caspases 3, 8 and 9 (Cell Signaling Technology Inc,
Beverly, MA) and b-actin (ICN; Costa Mesa, CA) were used at
ad i l u t i o no f1 : 1 0 0 0i nas o l u t i on containing 5% milk in TBS-
Tween (0.1%). Immunoreactive proteins were detected using
the enhanced chemiluminescence light (ECL) detecting kit
(Amersham Biosciences, Piscataway, NJ) as described previously
[35].
Macroscopic and confocal assessment of EGFP
expression
Mice were sacrificed at designated time points, the entire colon
dissected and then directly imaged for EGFP expression in a light-
tight imaging box without further preparation using a CCD
camera and emission filters specific for EGFP (Lightools Research;
Encinitas, CA).
For confocal microscopy, the colons were opened longitudinally
and placed on the stage of a Leica SP2 Upright Laser Scanning
Confocal Microscope (Leica, Germany), lumen side facing the
objective lens without further processing or fixation. EGFP was
excited with a 495 nm laser, and images were acquired using
detection filters specific for the EGFP emission spectrum. Images
were overlayed with those obtained using transmitted light,
allowing for spacial orientation relative to the shadows of the
crypts. Images were analyzed using the Leica SP2 Laser Scanning
Confocal Software (Leica, Germany).
PGE2 secretion
Luteolin-treated cells were stimulated with TNFa (5 ng/ml) for
24 h. A PGE2 enzyme linked immunosorbent assay (ELISA) of cell
culture supernatants was performed in triplicate according to the
manufacturer’s instructions (Assay Designs; Ann Arbor, MI).
RNA extraction and amplification by RT-PCR
RNA was isolated using the TRIzol method (Invitrogen; Carlsbad,
CA), reverse transcribed (1 mg RNA), and amplified as previously
described [35] using specific primers for mouse C-IAP1, C-IAP2,
X-IAP, COX-2 and b-actin. The PCR products were separated
on 2% agarose gels containing gel Star fluorescent dye (FMC;
Philadelphia, PA). Fluorescence staining was captured using an
Alpha Imager 2000 (AlphaInnotech; San Leandro, CA). Se-
quences of primers were 59-CAATTCGGCACCATAACTCTG-
39 and 59-CCTGTGGTTAAATCTGCCTTG-39 for human C-
IAP1 (amplicon length 1067 pb), 59-CAAGTAGATGAGGG-
TAACTGGC-39 and 59-AAGTTCCATCCCCTGTCCAATG-
39 for human C-IAP2 (amplicon length 550 pb), 59-CTTGCA-
TACTGTCTTTCTGAGC-39 and 59-ACACCATATACCC-
GAGGAAC-39 for human X-IAP (amplicon length 818 pb)
[36], 59-AGATCATCTCTGCCTGAGTATCTT-39 and 59-
TTCAAATGAGATTGTGGGAAAATTGCT-39 for human
COX-2 (amplicon length 304 pb) and 59-CCAACCGCGAGAA-
GATGACC-39 and 59-GATCTTCATGAGGTAGTCAGT-39
for human b-actin (amplicon length 235 pb).
DNA fragmentation analysis and apoptosis
detection
HT29 cells were grown in six well plates and at 80% of confluence
were treated with various amounts of luteolin and then stimulated
with TNFa (20 ng/ml) for 6, 12 and 24 hours. Cells were washed
twice with PBS and DNA was extracted with a hypotonic lysis
buffer (10 mM Tris, 1 mM EDTA and 0,2% Triton X-100, ph
7.5). Proteinase K digestion was carried out for 16 h at 37uC.
DNA was then extracted with phenol-chlorophorm-isoamyl-
alcohol (25:24:1). After ethanol precipitation and resuspension in
10 mM Tris, 1mM EDTA, ph 8.0, the DNA was electrophoresed
on a 1.5% agarose gel. A 100 bp DNA ladder (Life Technologies,
Rockville, MD) was used as a molecular weight standard. DNA
fragmentation was quantified by detecting histone-associated DNA
fragments in enzyme linked immunoabsorbance assay (ELISA)
(Boehringer Mannheim; Indianapolis, IN) according to the
manufacturer’s instructions.
Caspase Activity and Inhibition
Cells were pretreated with luteolin and then stimulated with TNFa
as indicated above. Cells were harvested, washed twice with PBS
and then lysed in Apopain Lysis Buffer (10 mM HEPES, ph 7.4,
2 mM EDTA, 0.1% CHAPS, 5 mM DTT, 1mM PMSF, 10 mg/
ml pepstatin A, 10 mg/ml aprotinin, 20 mg/ml leupeptin). Lysates
were cleared by centrifugation for 30 min at 12000 rpm in
a microfuge at 4uC. Protein content was measured using the Bio-
Rad protein quantification assay (Bio-Rad; Hercules, CA).
Caspase-3 activity was monitored in vitro using the fluorogenic
peptide substrate Z-DEVD-AFC (Bio-Rad; Hercules, CA).
Fluorescence changes derived from free AFC released by
caspase-3 activity were detected at 500–550 nm with a GeminiX
Spectrafluorometer (Molecular Devices; Sunnyvale, CA). Results
are presented in fold changes.
Luciferase adenoviral vector infection and luciferase
activity assay
HT29 cells were infected for 16 h with an adenoviral vector
encoding a NF-kB-luciferase reporter gene (Ad5kB-LUC) as
described previously [34]. The Ad5GFP containing GFP was used
as a viral vector infection negative control. The cells were washed,
and fresh medium containing serum was added. Cells were then
pretreated with various concentrations of luteolin or solvent
control for 45 min, after which time they were stimulated with
TNFa (5 ng/ml) for 12 h. Cell extracts were prepared using
luciferase cell lysis buffer (PharMingen; San Diego, CA) according
to the manufacturer’s instructions. Luciferase activity was
quantified using luciferase substrate solutions A and B from
PharMingen and read on a Lmax luminometer microplate reader
(Moleculer Devices; Sunnyvale, CA) and results were normalized
to protein concentration measured with the Bio-Rad protein
quantification assay (Bio-Rad; Hercules, CA).
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Restitution was assessed in rat non-transformed ileal epithelial cells
IEC-18 as previously described [37–39]. Briefly, IEC-18 cells were
grown to confluency in 100 mm cell culture dishes, starved in
serum-reduced media (1%) overnight and standard linear wounds
were created using a sterile razor-blade. Cells were then washed
once with PBS, and serum-reduced media was replenished.
Restitution was calculated as migration over the wound-edge over
24 hours.
Statistical analysis
Data are expressed as means6S.D. Groups of data (histological
scores, body weight) were analyzed using Kruskal-Wallis non-
parametric test and if the result indicated statistical differences
(p,0.05) among groups, comparisons between groups were
conducted using Mann-Whitney U test. Differences were consid-
ered significant if p,0.05. In vitro experiments were conducted in
triplicates; representative results are shown. For in vitro experi-
ments, data were analyzed by non-parametric t-test or Wilcoxon
rank sum test where appropriate. Differences were considered
significant if 2-tailed p values were ,0.05.
RESULTS
Luteolin-treatment worsens DSS-induced
experimental colitis
Although the anti-inflammatory potential of the flavonoid luteolin
has been established in vitro [18,21–23], its therapeutic impact on
different inflammatory disorders is still unclear. We tested the
effect of luteolin in a murine model of chemical-induced acute
intestinal inflammation. An NF-kB
EGFP transgenic mouse recently
generated by our group allows the assessment of the kinetics and
cellular localization of NF-kB-induced transcription (EGFP
expression) during an inflammatory response [25]. NF-kB
EGFP
mice (C57Bl/6; 7/group) were fed an isoflavone-free (AIN-76) or
2% luteolin diet for 3 days before being exposed to 3% DSS in
drinking water ad libitum or tap water control. Mice were then
sacrificed at day 6 and inflammation evaluated using established
clinical and histological parameters [30,31]. Surprisingly, although
luteolin has systemic anti-inflammatory properties in vivo [18],
luteolin-fed animals lost more weight than control diet-fed mice
(8.8% versus 2.3% at day 4, 15.4% versus 10.2% at day 6,
p,0.05) (Fig. 1A). Moreover, histological evaluation demonstrated
significantly worse colitis in mice fed the luteolin chow compared
to the AIN-76 control chow (Fig. 1B). Colitis was also exacerbated
in mice fed a 0.5% or a 5% luteolin rich diet compared to AIN-76
control diet (data not shown). Mice fed with luteolin chow alone
and exposed to water did not develop any signs of colitis (data not
shown). These findings demonstrate that the flavonoid luteolin
worsens DSS-induced colitis in mice.
Luteolin-fed, DSS exposed NF-kB
EGFP mice display
strong EGFP expression in the intestine
To gain insight into the molecular mechanisms involved in the
worsening of colitis in luteolin-fed mice, we investigated the in vivo
pattern of NF-kB activity. The colons of 2% luteolin or AIN-76
fed DSS-treated NF-kB
EGFP mice were dissected and imaged
using a CCD camera in a light-tight imaging box with a dual
filtered light source and emission filters specific for EGFP. As seen
in Fig. 2A, EGFP expression is strongly enhanced throughout the
colon of DSS-exposed animals compared to water-control mice
(left panel). Of note, there was no difference in the macroscopic
EGFP expression in duodenal and proximal jejunal sections of the
same mice (Fig. 2A; right panel). This suggests that enhanced
colonic EGFP expression correlates with DSS-induced colonic
damage. Interestingly, colonic EGFP expression was not blocked
in mice fed the 2%-luteolin diet, but rather showed enhanced
expression, especially in the distal colon (Fig. 2A).
To examine the expression of EGFP at the cellular level, we
visualized the distribution of the EGFP-positive cells present in
colonic segments freshly harvested from NF-kB
EGFP mice using
confocal microscopy. As seen in Fig. 2B, EGFP expression was
increased in colons from mice fed the 2%-luteolin diet compared
to those from untreated, DSS-exposed mice. Higher magnification
images demonstrated that the increased EGFP expression was
confined to interstitial mononuclear cells between crypts (Fig. 2B;
schematic representation shown in Fig. 2C). These findings
indicate that luteolin enhances DSS-induced colitis, which
correlates with increased NF-kB activation (EGFP expression)
from colonic mucosa lamina propria mononuclear cells (LPMNC).
Decreased COX-2 gene expression and enhanced
caspase 3 activation in luteolin fed mice following
DSS exposure
DSS-induced colitis is exacerbated in COX-2 gene deficient mice
[40], and a recent report demonstrated the importance of
enterocyte-derived COX-2 gene expression for the amelioration
of DSS-induced epithelial damage [41]. Since we previously
showed that luteolin prevents NF-kB activation in enterocytes
[18], we next investigated whether intestinal epithelial COX-2
expression is down-regulated in luteolin-fed mice.
Molecular alterations likely precede clinical signs of colitis and
histopathological evidence of inflammation that generally occur
after 3–4 days of DSS exposure in mice (Fig. 1A and data not
shown). Therefore, we examined COX-2 expression by Western
blot in enterocytes isolated from AIN-76-chow or 2%-luteolin-
chow fed mice exposed to 3% DSS for only 2 days. Interestingly,
COX-2 protein levels were higher in enterocytes isolated from
DSS-exposed mice compared to those isolated from controls, and
this effect was abrogated by luteolin treatment (Fig. 3A, left). A
similar though less pronounced effect on COX-2 gene expression
could be observed in total colonic protein extracts (Fig. 3A, right).
Immunohistochemistry also demonstrated a strong decrease of
DSS-induced COX-2 expression in enterocytes in mice fed the
2%-luteolin-chow (Fig. 3B; top panel). Isotype antibody control
demonstrated the specificity of the staining (Fig. 3B; bottom panel).
These results suggest that luteolin interferes with DSS-induced
enterocyte-derived COX-2 gene expression.
NF-kB signaling controls numerous cellular events including cell
survival through induction of anti-apoptotic genes [42,43]. We
next investigated whether luteolin would inhibit anti-apoptotic
signaling in enterocytes, a process that would enhance intestinal
epithelial damage by DSS. Interestingly, a small increase in
caspase 3 processing was observed in isolated enterocytes (Fig. 3A,
left), although baseline processing is strongly increased in these
cells compared to total colonic lysates. This is likely due to cell
detachment-induced apoptosis (anoikis) caused by the isolation
procedure [44]. Importantly, total colonic protein obtained from
luteolin-fed DSS-treated mice displayed a significant increase in
caspase 3 processing compared to AIN-76-fed and DSS-treated or
water control treated mice (Fig. 3A, right). Furthermore, enhanced
caspase 3 processing is detected in enterocytes from luteolin-fed,
DSS-exposed mice compared to control diet as determined by
immunohistochemical analysis (Fig. 3B; middle panel). These
results suggest that luteolin increases enterocyte caspase 3
activation after DSS-exposure.
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dependent colitis and EGFP expression in IL-10
2/2;
NF-kB
EGFP mice
We next asked if the NF-kB-inhibiting properties of luteolin might
be beneficial in a spontaneous model of chronic, Th1-mediated
intestinal inflammation. Germ-free IL-10
wt/wt;NF-kB
EGFP and IL-
10
2/2;NF-kB
EGFP mice were transferred to a specific-pathogen-
free (SPF) environment and immediately placed on a diet
containing 2% luteolin versus AIN-76 control-chow (7/group).
After 4 weeks, mice were sacrificed, sections were taken from
cecum and distal colon for histological assessment of inflammation
and EGFP expression was imaged as described above. In-
terestingly, IL-10
2/2 mice fed with the control diet showed
thickening of the colon and absence of solid stool compared to
wild-type mice, whereas luteolin-fed IL-10
2/2 mice displayed
a macroscopically healthy colon with abundant and well-formed
stool pellets (Fig. 4A). Furthermore, luteolin-treatment decreased
cecal EGFP expression in IL-10
2/2;NF-kB
EGFP mice (Fig. 4A).
Histological assessment of inflammation showed that luteolin
treatment ameliorated cecal inflammation in IL-10
2/2;NF-
kB
EGFP mice (Fig. 4B). Distal colonic inflammation and EGFP
expression were comparable between luteolin and AIN76 control-
fed mice (Fig. 4A,B). Thus, these results do not demonstrate
Figure 1. 2% luteolin diet worsens DSS-induced experimental colitis as measured by weight loss and histologic score. 2% luteolin or AIN-76 fed
mice (n=7 per group) were exposed to 3% DSS in drinking water ad libitum for the indicated time and monitored as described in the Methods
section. Weight loss in response to DSS is presented as percent of the starting weight (* p,0.05 versus control, # p,0.05 versus DSS alone) (A).
Colonic histological sections were scored as described in the Methods section (* p,0.05 versus control, # p,0.05 versus DSS alone) (B).
doi:10.1371/journal.pone.0000596.g001
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EGFP mice as compared to control diet is confined to lamina propria
mononuclear cells. NF-kB
EGFP mice (n=7 per group) were sacrificed after 6 days of 3% DSS exposure, and dissected colon (left panel) and
duodenum/proximal jejunum (right panel) were imaged at this time for EGFP using the Lightools Research macroimaging system with a dual output
lighting (right). Photomicrographs (Nikon cool-pix digital camera) are shown on the left. Representative images are shown (A). Confocal imaging of
colonic sections from NF-kB
EGFP mice (n=3 per group) after 6 days of 3% DSS exposure was performed immediately after dissection as described in
the Methods. Representative results are shown (B). A schematic representation of the colon indicates the plane depicted in the confocal microscopic
images. Importantly, EGFP accumulation (NF-kB activation) is predominantly seen in lamina propria mononuclear cells located in between the crypts
(LPMNC, light purple and green), and not in surface and crypt epithelium, which is damaged by DSS (light grey) (C).
doi:10.1371/journal.pone.0000596.g002
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2/2 mice, but rather suggest
a potential beneficial impact of this flavonoid in a model of
spontaneous chronic T cell-mediated colitis.
Luteolin-treatment sensitizes human colonic
intestinal epithelial cells HT29 to TNFa-induced
apoptosis
We next characterized the impact of luteolin on TNFa-induced
NF-kB activity, COX-2 and anti-apoptotic gene expression in
vitro, using the human colon epithelial cell line HT29. Cells were
infected for 16 h with an adenoviral vector encoding an NF-kB-
luciferase reporter gene (Ad5kB-LUC), pretreated with various
doses of luteolin (25 mM, 50 mM or 100 mM) for 45min and then
stimulated with TNFa (5 ng/ml) for 12 h. As shown in Fig. 5A,
luteolin (100 mM) inhibited TNFa-induced NF-kB transcriptional
activity in HT29 cells. NF-kB-dependent anti-apoptotic genes
include the cellular inhibitors of apoptosis protein-1 and -2 (C-
IAP1 and C-IAP2), which selectively block the key pro-apoptotic
enzymes caspase-3, -8 and -9. Interestingly, luteolin treatment
completely suppressed TNFa-induced C-IAP1 and C-IAP2
mRNA accumulation, whereas X-IAP mRNA levels remained
unchanged as measured by RT-PCR (Fig. 5B). Thus, luteolin
prevents TNFa-induced NF-kB activity and anti-apoptotic gene
induction.
We next asked whether luteolin functionally impacts on HT29
cell apoptosis in the presence of TNFa. Cells were pretreated with
luteolin (50 mM or 100 mM) for 45 min, and then exposed to
TNFa (20 ng/ml) for 24 h, after which time genomic DNA was
isolated. As seen in Fig. 6A, luteolin-treatment (100 mM) led to
TNFa-induced DNA fragmentation in HT29 cells. Quantitative
assessment of DNA fragmentation by ELISA assay for cytoplasmic
oligonucleosome-bound DNA demonstrated a 2.2fold induction of
DNA fragmentation in luteolin-pretreated TNFa stimulated cells
by 12 h, which increased to 8.1fold by 24 h post-treatment
(Fig. 6B). Thus, luteolin treatment leads to TNFa-induced DNA
fragmentation in HT29 cells in vitro.
Caspase-3 processing is enhanced in luteolin-fed mice exposed
to DSS (Fig. 3A,B). We next investigated the impact of this
flavonoid on caspase activity in the presence of TNFa. HT29 cells
were treated with luteolin (100 mM) for 45 min, then treated with
TNFa (20 ng/ml) for 24 h and caspase processing was determined
by Western blot analysis. As shown in Fig. 7A, luteolin strongly
induced caspase-3, -8 and -9 processing in the presence of TNFa.
Moreover, luteolin induced caspase-3 activity in the presence of
TNFa as demonstrated by a fluorescence-based assay (Fig. 7B; 2.5
fold after 12 h treatment, 7.5 fold after 24 h treatment). The
kinetics of caspase activation parallel those of DNA fragmentation
(Fig. 6B). In summary, luteolin blocks TNFa-induced NF-kB
transcriptional activity and anti-apoptotic gene expression, but
induces caspase-3, -8 and -9 processing in HT29 cells in the
presence of TNFa in vitro.
Luteolin-treatment suppresses TNFa-induced COX-2
gene expression
The NF-kB-dependent COX-2 gene has been associated with
a protective host response during DSS-induced colitis [40,41]. In
addition, COX-2 gene expression has been shown to promote
intestinal epithelial cell restitution [37]. We next assessed the
impact of luteolin on TNFa-induced COX-2 gene expression in
HT29 cells. Cells were treated with luteolin (100 mM) for 45 min,
then treated with TNFa (5 ng/ml) for 12 h and 24 h and COX-2
mRNA and protein accumulation were determined by RT-PCR
and Western blot analysis, respectively. As seen in Fig. 8, luteolin
completely blocked TNFa-induced COX-2 mRNA accumulation
(Fig. 8A) and protein expression (Fig. 8B) in HT29 cells. Similarly,
TNFa-induced PGE2 secretion is blocked in luteolin-treated HT29
cells (Fig. 8C).
DISCUSSION
NF-kB drives the expression of a subset of target genes that have
important functions in salvaging enterocytes from apoptosis and in
promoting restitution in various models of gastrointestinal
damage. For example, ischemia-reperfusion and radiation-induced
intestinal injury is worse in mice with selective IKKb deletion in
enterocytes [45,46]. Also, DSS-induced colitis is exacerbated in
MyD88
2/2 mice, a critical adaptor protein involved in TLR-
induced NF-kB signaling [47]. Interestingly, PGE2-expressing
stromal cells within the lamina propria reposition near the
intestinal epithelial stem cell compartment following DSS-induced
injury through a MyD88-dependent mechanism, a process pro-
moting cellular proliferation and mucosal healing [48]. Notewor-
thy, we found that luteolin inhibits DSS-induced, NF-kB de-
pendent enterocyte COX-2 expression in both total colonic
protein extracts and purified enterocytes obtained from luteolin-
fed mice. Similarly, in vitro experiments showed that luteolin
blocks TNFa-induced COX-2 gene expression and PGE2
secretion in HT29 cells. Interestingly, luteolin attenuated restitu-
tion in a wound-healing assay in rat intestinal epithelial cells IEC-
18 in vitro (69% of control, p,0.01), which was partially restored
by adding exogenous PGE2 (87% of control, p,0.01 versus
luteolin treatment alone). Thus, COX-2 and its derivative
metabolites seem to play an important role in maintaining
mucosal homeostasis. Of note, it should be stressed that although
blocking COX-2 expression appears detrimental in the DSS
model of acute colitis, a luteolin-rich diet may be beneficial in
preventing colorectal cancer, where COX-2 overexpression is
associated with carcinogenesis [49–51].
Exacerbated colitis in luteolin-treated, DSS-exposed mice
may involve a higher susceptibility of enterocytes to undergo
signal-induced apoptosis and a decreased ability to initiate
restitution. This possibility is supported by our findings that
luteolin fed mice displayed enhanced caspase 3 processing in
colonic tissue following DSS exposure, suggesting a higher rate
of apoptosis. In addition, in vitro experiments showed that
luteolin sensitizes HT29 cells to TNFa-induced caspase-3
processing/activity as well as DNA fragmentation. These effects
were associated with blockade of TNFa-induced NF-kB
transcriptional activity and the concomitant decreased expres-
sion of down-stream target genes C-IAP1 and C-IAP2. The
failure to maintain an intact intestinal epithelium and to repair
DSS-induced intestinal epithelial damage would result in an
increased uptake of luminal antigens, including bacteria and
bacterial products, and thus lead to the activation of underlying
immune cells and the mounting of an inflammatory response: In
the DSS model of acute chemical-induced colitis, luteolin’s
foremost impact is likely geared towards enterocytes, inhibiting
NF-kB-dependent protective molecules. Enhanced injury then
leads to enhanced NF-kB activation (EGFP expression) in
mononuclear cells from the colonic lamina propria, where
luteolin’s inhibitory effect on NF-kB in LPMNC is likely
overcome by the strong impact of abundantly translocated
luminal antigens. Enhanced lamina propria NF-kB activation
( E G F Pe x p r e s s i o n )i nt u r nc o r r e l a t e sw i t hc l i n i c a la n dh i s t o l o g -
ical signs of colitis in luteolin-fed mice (Fig. 9A,C).
Numerous pro-inflammatory mediators are known to be
associated with the development of DSS-induced acute inflam-
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PLoS ONE | www.plosone.org 7 July 2007 | Issue 7 | e596Figure 3. 2% luteolin enhances caspase 3 activation and suppresses COX-2 protein accumulation in enterocytes after DSS exposure. NF-kB
EGFP
mice (n=7/group) were sacrificed after 2 days of 3% DSS exposure and protein (20 mg) from primary enterocytes (A, left) and total colonic lysates (A,
right) were subjected to SDS-PAGE. COX-2 expression and caspase 3 processing were evaluated using specific antibodies against cleaved caspase 3
and COX-2, respectively, and immunoreactive proteins were detected using the enhanced chemiluminescence (ECL) technique (A). NF-kB
EGFP mice
(n=7/group) were sacrificed after 2 days of 3% DSS exposure, and cellular localization of COX-2 proteins (top panel) and caspase 3 processing
(middle panel) were analyzed in the colon using IHC. Sections were counterstained with a mixture of methyl-green and alcian-blue. An isotype-
control antibody was used to determine staining specificity on the same colonic section (lower panel). Representative results out of 2 different
sections per each animal (n=14/group) are shown (B).
doi:10.1371/journal.pone.0000596.g003
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Whether TNFa promotes intestinal injury and apoptosis in
luteolin-fed DSS-treated mice remains to be formally shown.
Similarly, the exact signaling events associated with enhanced
COX-2 expression, NF-kB activity and caspase-3 processing in
DSS-exposed mice are as of yet unclear.
Importantly, luteolin’s negative impact on acute gastrointestinal
damage by DSS does not impair its potential therapeutic benefits
Figure 4. 2% luteolin diet ameliorates cecal colitis and decreases lamina-propria EGFP expression in SPF-associated IL-10
2/2;NF-kB
EGFP mice.
Germ-free IL-10
wt/wt;NF-kB
EGFP and IL-10
2/2;NF-kB
EGFP mice were transferred to a specific-pathogen-free (SPF) environment and immediately placed
on a diet containing 2% luteolin versus AIN-76 control chow (7/subgroup). After 4 weeks, mice were euthanized, and colonic EGFP-expression was
imaged macroscopically and by confocal microscopy as described in figure 2 (A). Colonic histological sections from 4 weeks SPF-associated IL-10
wt/
wt;NF-kB
EGFP and IL-10
2/2;NF-kB
EGFP mice were taken and scored as described in the Methods section (* p,0.05 versus AIN-76 control chow) (B).
doi:10.1371/journal.pone.0000596.g004
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PLoS ONE | www.plosone.org 9 July 2007 | Issue 7 | e596Figure 5. Luteolin blocks TNFa-induced NF-kB activity and suppresses TNFa-induced C-IAP1 and C-IAP2 mRNA accumulation in HT29 cells. HT29
cells were infected with Ad5kB-LUC, and TNFa (5 ng/ml) was added in the presence or absence of various concentrations of luteolin. Luciferase
activity after 16h was measured using an Lmax microplate reader and results were normalized for extract protein concentrations. Representative
results of at least 3 independent experiments are shown (* p,0.01 versus TNFa alone) (A). HT29 cells were pretreated with luteolin (100 mM) for
45min, and then stimulated with TNFa (5 ng/ml) for 4 h. Total RNA (1 mg) was extracted, reverse-transcribed, and amplified using specific human C-
IAP1, C-IAP2, X-IAP and b-actin primers. Results are representative of three independent experiments (B).
doi:10.1371/journal.pone.0000596.g005
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PLoS ONE | www.plosone.org 10 July 2007 | Issue 7 | e596Figure 6. Luteolin-treatment sensitizes TNFa-exposed HT29 cells to DNA fragmentation and cytoplasmic accumulation of oligonucleosome-
bound DNA. HT29 cells were pretreated with various concentration of luteolin alone or in combination with TNFa (20 ng/ml) for 24 h. Cells were
lysed, DNA extracted and separated on a 1% agarose gel. Results are representative of three independent experiments (A). HT29 cells were treated as
described above for 12 and 24 h. Cells were lysed and apoptosis measured using an ELISA-based assay as described in the Method section.
Representative results of at least 3 independent experiments are shown (* p,0.01 versus TNFa alone) (B).
doi:10.1371/journal.pone.0000596.g006
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2/2 mice. In
this spontaneous model of chronic, Th1-mediated intestinal
inflammation, without primary epithelial damage, luteolin’s
inhibition of NF-kB activation (EGFP expression) is predominant-
ly seen in lamina propria mononuclear cells (LPMNC). Its actions
at least in part ameliorate the clinical and histological signs of
Figure 7. Luteolin-treatment induces caspase 3, 8 and 9 activation in the presence of TNFa in HT29 cells. HT29 cells were treated with luteolin
(100 mM) alone or in combination with TNFa (20 ng/ml) for 12 h. Cells were lysed, protein extracts (20 mg) were subjected to SDS-PAGE (13%) and
caspase 3, 8 and 9 processing was evaluated by Western blot using specific antibodies for cleaved caspases 3, 8 and 9. Immunoreactive proteins were
detected using the enhanced chemiluminescence (ECL) technique. Representative results of at least 3 independent experiments are shown (A). Cells
were treated as described above for 12 and 24 h. Cells were lysed and caspase 3 activity was quantified using a fluorescence-based assay as described
in the Method section. Representative results of at least 3 independent experiments are shown (* p,0.01 versus TNFa alone at 24 h) (B).
doi:10.1371/journal.pone.0000596.g007
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PLoS ONE | www.plosone.org 12 July 2007 | Issue 7 | e596Figure 8. Luteolin-treatment inhibits TNFa-induced COX-2 gene expression in HT29 cells. HT29 cells were pretreated with luteolin (100 mM) for
45 min, and then stimulated with TNFa (5 ng/ml) for 4 h. Total RNA (1 mg) was extracted, reverse-transcribed, and COX-2 mRNA was amplified using
specific human primers (A). Cells were treated as described above for 12 h and 24 h, and COX-2 protein accumulation was detected using Western
blot analysis (B). Cells were treated as described above for 24 h and PGE2 production was measured from the cell culture supernatants using ELISA (*
p,0.01 versus TNFa plus luteolin) (C). All data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0000596.g008
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our recent report demonstrating a beneficial impact of pharma-
cological NF-kB inhibition on colitis in IL-10
2/2 mice [8]. Our
results warrant further studies of luteolin’s effects in colonic
dysplasia and cancer development as well as in chronic intestinal
inflammation. Since herbal compounds and their derivatives are
widely available and taken by an increasing number of patients
oftentimes without proper medical monitoring, our study stresses
the need for further analysis of their impact on various diseases.
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